Arterys company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

arterys.com

Founded Year

2011

Stage

Series C | Alive

Total Raised

$70M

Last Raised

$28M | 2 yrs ago

About Arterys

Arterys provides automated, intelligent cloud-based software that uses real-world clinical data to make imaging more accurate and data driven. Arterys develops 4D Flow technology, which generates precise measurements of blood flow noninvasively and non-radiatively anywhere in the body, and enables physicians to visualize and analyze blood flow inside the heart in 3D with automatic, interactive reporting.

Arterys Headquarter Location

51 Federal Street Suite 305

San Francisco, California, 94107,

United States

650-319-7230

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Arterys

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Arterys in 4 CB Insights research briefs, most recently on Feb 16, 2022.

Expert Collections containing Arterys

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Arterys is included in 9 Expert Collections, including Digital Health.

D

Digital Health

21,922 items

Startups recreating how healthcare is delivered

A

AI 100

199 items

C

Conference Exhibitors

5,501 items

HLTH is a healthcare event bringing together startups and large companies from pharma, health insurance, business intelligence, and more to discuss the shifting landscape of healthcare

A

Artificial Intelligence

9,093 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

D

Digital Health 150

300 items

2019's cohort of the most promising digital health startups transforming the healthcare industry

M

Medical Devices

11,739 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

Arterys Patents

Arterys has filed 23 patents.

The 3 most popular patent topics include:

  • Medical imaging
  • Magnetic resonance imaging
  • Image processing
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/25/2018

1/26/2021

Cardiac anatomy, Cardiac arrhythmia, Cardiovascular physiology, Cardiology, Heart diseases

Grant

Application Date

1/25/2018

Grant Date

1/26/2021

Title

Related Topics

Cardiac anatomy, Cardiac arrhythmia, Cardiovascular physiology, Cardiology, Heart diseases

Status

Grant

Latest Arterys News

FDA Clears Arterys\' AI Mapping and Quantification Tools

May 20, 2022

Company also releases its next-generation Cardio AI application. Michael Barbella, Managing Editor05.20.22 Arterys has received U.S. Food and Drug Administration (FDA) clearance for its artificial intelligence-powered mapping and quantification tools. The FDA green light—the company's eighth—was bestowed upon Arterys’ modules for T1 mapping and T2 quantification. The T1 mapping tool, which also calculates extracellular volume fraction (ECV), looks for variations in the heart muscle’s tissue. Those findings can then be used to diagnose conditions like myocardial inflammation, fibrosis and hypertrophy, while the ECV calculations measure the empty space in the tissue that may also play host to certain myocardial diseases. T2 quantification, meanwhile, provides another characterization of the tissue of the heart muscle, helping physicians assess the severity of a case of myocardial infarction and detect swelling in patients with the condition. These now-cleared modules offer a dedicated workflow for T1 and ECV, and T2 quantification, including multiple and global ROIs, and a graphical display of curves that provides users with intuitive, simple calculations for tissue characterization. "With the addition of our new modules, we are able to accommodate a wide variety of users from community hospitals/physician centers to larger research centers and even pediatrics," said Michelle Buekes, product manager, Cardio AI at Arterys. "We are very excited to continue to work with our customers and partners to build upon and improve our product to meet the needs of an evolving and growing field." In addition to the FDA clearance, Arterys announced several new modules to Cardio AI, a comprehensive, cloud-based post-processing solution that leverages AI and deep learning to provide extremely accurate, automated, fast, repeatable analysis of cardiac MRI images. The latest Cardio AI enhancements provide physicians with additional tools to remove redundant work and tedious editing to analyze Cardiac MRI images. These new modules make it easier for physicians to manage the increasing demand and provide consistent diagnostic decisions more efficiently. The latest modules include: Strain + AIPowered by 4D Flow — Incorporates a deep learning myocardial velocity and strain model that eliminates the need for time-consuming contour editing to obtain reliable strain results (available for research only). Atrial Volumes — Allows physicians to easily quantify volumes for both left and right atria in cardiac MRI images to aid in the diagnostic process. Wall Thickness — Provides automatic wall thickness measurements critical to the diagnosis process. "Cardio AI is an integral part of our image interpretation and patient management," said Ali B Syed, M.D., of Stanford School of Medicine, Department of Radiology. "It significantly reduces the time necessary to generate useful information from our imaging. What used to take 30 minutes or more is now done, in many cases, before the patient is even off of the MRI table. It has also accelerated our adoption of techniques like T1 mapping and quantitative delayed enhancement because it dramatically reduces the effort to report these values. "   "Cardio AI has been an invaluable tool in our practice to allow us faster processing of complex cardiac MR examinations with automated contouring not only for function but also tissue characterization saving us minutes of processing time on every single exam," said Melany B. Atkins, M.D., Division Chief, Body/Cardiovascular Imaging at Inova Fairfax Hospital. "Rapid processing of 4D Flow affords us the ability to evaluate complex congenital heart disease nearly real-time. "     Arterys is the world's first internet platform for medical imaging. Its objective is to transform healthcare by transforming radiology. The Arterys platform is 100 percent web-based, AI-powered, and FDA-cleared, unlocking simple clinical solutions.

Arterys Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Arterys Rank

  • When was Arterys founded?

    Arterys was founded in 2011.

  • Where is Arterys's headquarters?

    Arterys's headquarters is located at 51 Federal Street, San Francisco.

  • What is Arterys's latest funding round?

    Arterys's latest funding round is Series C.

  • How much did Arterys raise?

    Arterys raised a total of $70M.

  • Who are the investors of Arterys?

    Investors of Arterys include Emergent Medical Partners, Temasek, Varian Medical Systems, Fosun Capital, Benslie Investment Group and 14 more.

  • Who are Arterys's competitors?

    Competitors of Arterys include Koios Medical, Aidoc Medical, Qure.ai, Viz.ai, Circle Cardiovascular Imaging and 15 more.

You May Also Like

A
Aidoc Medical

Aidoc finds and flags critical findings in medical images. By automatically prioritizing urgent, life-threatening conditions like intracranial hemorrhage and pulmonary embolism, Aidoc saves lives, improves patient care and cuts waiting time for the must urgent patients down to only a few minutes. The always-on AI integrates into a radiologist's workflow, reprioritizing cases without forcing radiologists to change the way they work. Aidoc was founded in 2016 and is based in Tel Aviv, Israel.

Ultromics Logo
Ultromics

Ultromics is a global health technology company that provides autonomous echocardiography analysis through AI solutions – empowering physicians to make fast, accurate decisions when diagnosing cardiovascular disease. Its cloud-based service, EchoGo, uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site.

QUIBIM Logo
QUIBIM

Quibim, a company with its headquarters in Valencia, Spain, provides a whole-body medical imaging analysis. Quibim products are used worldwide by a huge diversity of research and care teams. Partners use Quibim Precision, a CE-marked whole-body imaging ecosystem, for a wide range of applications from detecting a disease to tracking the efficacy of treatments. Quibim follows an AI-first approach to help detect pathologies across every body part and imaging modality, using quantitative imaging biomarkers.

Enlitic Logo
Enlitic

Enlitic develops a diagnosis system that uses deep learning to analyze medical data in order to enable quick and more accurate detection of diseases that can be identified through medical images such as X-rays and CT scans.

Infervision Logo
Infervision

Infervision is a global high-tech enterprise in medical artificial intelligence, aiming to empower doctors with higher efficiency and benefit patients with better diagnosis, outcome, and lower cost. Infervision provides products and services to providers, and patients; with robust A.I. solutions fully integrated with the healthcare workflow to help diagnosing various diseases and conditions such as cerebral hemorrhage, lung cancer, bone fractures, emphysema, and more. Infervision also provides an AI-powered research platform for medical professionals with any research directions and needs.

Perspectum Logo
Perspectum

Perspectum is a provider of digital technologies that help clinicians provide better care for patients with liver disease. The company's work focuses on the detection and accurate, quantitative measurement of liver, gall bladder, and pacreatic disease.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.